Bioxcel Therapeutics Announces $260 Million Strategic Financing With Oaktree And Qatar Investment Authority
Amount Raised
$260 Million
Round Type
Venture
New HavenBiotechnologyTherapeuticsBiopharmaDescription
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (the “Company” or “BioXcel Therapeutics”), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced strategic financing agreements with funds managed by Oaktree Capital Management, L.P. (“Oaktree”) and Qatar Investment Authority (“QIA”). Under the agreements, Oaktree and QIA will provide up to $260 million in gross funding to support the Company’s commercial activities of IGALMITM (dexmedetomidine) sublingual film
Quick answer
BioXcel Therapeutics raised $260 Million in a funding round, dated April 19, 2022. BioXcel Therapeutics is based in New Haven, Connecticut, United States.
- How much did BioXcel Therapeutics raise?
- BioXcel Therapeutics raised $260 Million in a funding round on April 19, 2022.
- What does BioXcel Therapeutics do?
- BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric diseases.
- Where is BioXcel Therapeutics based and how big is it?
- BioXcel Therapeutics is based in New Haven, Connecticut, United States. Fundz records about 53 employees.
- Who are the decision-makers at BioXcel Therapeutics?
- Fundz holds 2 contacts at BioXcel Therapeutics, including the VP, Head of Quality and Compliance. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as BioXcel Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Gilead Sciences raised $42M (Series F) on June 1, 2022.
- Tempest Therapeutics raised $15M on May 11, 2022.
- BioNTech raised $150M on April 14, 2022.
- Edesa Biotech raised an undisclosed amount on April 5, 2022.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
- Orna Therapeutics raised an undisclosed amount (Seed) on May 25, 2022.
Who to call at BioXcel Therapeutics, and when
A new round usually means BioXcel Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioXcel Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioXcel Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioXcel Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioXcel Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioXcel Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.